Medicare Advantage
  
  
  
  
  
  
  
  
  
  
MPattachmentdataPub
  
e6ab9a34-6c77-4168-b73e-e42a6a23b38f.aspx
  
1956Abatacept(Orencia®)forInjectionforIntravenousUseMA08.028ePharmacy (08)MA08.028eMA08.028e6ab9a34-6c77-4168-b73e-e42a6a23b38fAbatacept (Orencia®) for Injection for Intravenous UseAbatacept (Orencia®) for Injection for Intravenous Use
{"1957": {"Id":1957,"MPAttachmentLetter":"A","Title":"ICD-10 codes","MPPolicyAttachmentInternalSourceId":4836,"PolicyAttachmentPageName":"f8fe6bdc-30ad-47b8-a27f-01f1cdeffc2f"},}
5e7d70e9-cd59-4945-8fd8-e5552ecdbe7f.aspx
  
2507AbortionMA11.010aSurgery (11)MA11.010aMA11.0105e7d70e9-cd59-4945-8fd8-e5552ecdbe7fAbortionAbortion
5ed85e0b-9cd1-4e89-9257-01f59ad720f1.aspx
  
2615AcupunctureMA12.004bMiscellaneous (12)MA12.004bMA12.0045ed85e0b-9cd1-4e89-9257-01f59ad720f1AcupunctureAcupuncture
{"2616": {"Id":2616,"MPAttachmentLetter":"A","Title":"ICD-10 CM Codes Eligible to be Reported for Acupuncture","MPPolicyAttachmentInternalSourceId":5412,"PolicyAttachmentPageName":"61086ead-80c0-4588-b615-6c859629e3a9"},}
85257D39006E7945852585970047577D.aspx
  
1344Acute Care Facility Inpatient TransfersMA12.003aMA12.00385257D39006E7945852585970047577DAcute Care Facility Inpatient TransfersAcute Care Facility Inpatient Transfers
53c4e67b-3cda-4ec6-8248-67773a3ce433.aspx
  
2306Ado-TrastuzumabEmtansine(Kadcyla®)MA08.066dPharmacy (08)MA08.066dMA08.06653c4e67b-3cda-4ec6-8248-67773a3ce433Ado-Trastuzumab Emtansine (Kadcyla®)Ado-Trastuzumab Emtansine (Kadcyla®)
{"2307": {"Id":2307,"MPAttachmentLetter":"A","Title":"ICD-10 CODES AND NARRATIVES","MPPolicyAttachmentInternalSourceId":4968,"PolicyAttachmentPageName":"007b8aa2-9b71-4ef1-b91e-6774ea67dbce"},}
85257D39006E7945852585430046609C.aspx
  
1645Agalsidase beta (Fabrazyme®)Pharmacy (08)MA08.033bMA08.03385257D39006E7945852585430046609CAgalsidase beta (Fabrazyme®)Agalsidase beta (Fabrazyme®)
85257D39006E79458525859700487CB6.aspx
  
1345Air Ambulance ServicesMiscellaneous (12)MA12.007aMA12.00785257D39006E79458525859700487CB6Air Ambulance ServicesAir Ambulance Services
85257D39006E7945852584EB0059DBD8.aspx
  
1666Alemtuzumab (Lemtrada™)MA08.015dMA08.01585257D39006E7945852584EB0059DBD8Alemtuzumab (Lemtrada™)Alemtuzumab (Lemtrada™)
85257D39006E794585258543004566E0.aspx
  
1646Alglucosidase alfa (e.g., Lumizyme®)Pharmacy (08)MA08.036cMA08.03685257D39006E794585258543004566E0Alglucosidase alfa (e.g., Lumizyme®)Alglucosidase alfa (e.g., Lumizyme®)
719b74d6-420c-4235-bd9c-701076317da1.aspx
  
2592AllergyImmunotherapyMA07.055dMedicine (07)MA07.055dMA07.055719b74d6-420c-4235-bd9c-701076317da1Allergy ImmunotherapyAllergy Immunotherapy
3f61cbc3-b488-474e-9b87-7af08a0d7a37.aspx
  
2305Alpha1-AntitrypsinTherapy(e.g.,Prolastin-C,AralastNP,Glassia,Zemaira)MA08.050bPharmacy (08)MA08.050bMA08.0503f61cbc3-b488-474e-9b87-7af08a0d7a37Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)
35a0adbf-ef85-4e9f-9667-971a77f78cd8.aspx
  
2537AlwaysBundledProcedureCodesMA00.026jAdministrative (00)MA00.026jMA00.02635a0adbf-ef85-4e9f-9667-971a77f78cd8Always Bundled Procedure CodesAlways Bundled Procedure Codes
{"2538": {"Id":2538,"MPAttachmentLetter":"A","Title":"Always Bundled Procedures (MPFSD Indicator B)","MPPolicyAttachmentInternalSourceId":5431,"PolicyAttachmentPageName":"c5c118a4-b82d-42da-8e4d-28c90f57ebff"},"2539": {"Id":2539,"MPAttachmentLetter":"B","Title":"Procedures/Services Not Eligible for Separate Reimbursement","MPPolicyAttachmentInternalSourceId":5432,"PolicyAttachmentPageName":"c344955b-beb4-4a7b-a0b4-c62cf1a1d29e"},"2540": {"Id":2540,"MPAttachmentLetter":"C","Title":"Procedures/Services Not Eligible for Reimbursement","MPPolicyAttachmentInternalSourceId":5433,"PolicyAttachmentPageName":"c715154c-b132-4047-a6ec-bf6814cf13f4"},}
301346f4-5db6-4773-ade7-a8c8bddfe5fe.aspx
  
2460AmbulatoryBloodPressureMonitoring(ABPM)andHomeBloodPressureMonitoring(HBPM)DevicesMA07.005cMedicine (07)MA07.005cMA07.005301346f4-5db6-4773-ade7-a8c8bddfe5feAmbulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) DevicesAmbulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) Devices
29fb4d0d-8653-4ba0-ad75-1478a34f9c92.aspx
  
2315AmbulatoryElectrocardiography(AECG)MonitoringandMobileCardiacOutpatientTelemetry(MCOT)MonitoringMA07.026fMedicine (07)MA07.026fMA07.02629fb4d0d-8653-4ba0-ad75-1478a34f9c92Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) MonitoringAmbulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring
323e74cd-c91b-477a-9f9a-790d2bc1dbc7.aspx
  
2524Ankle-Foot/Knee-Ankle-FootOrthosesMA05.010fDME (05)MA05.010fMA05.010323e74cd-c91b-477a-9f9a-790d2bc1dbc7Ankle-Foot/Knee-Ankle-Foot OrthosesAnkle-Foot/Knee-Ankle-Foot Orthoses
{"2525": {"Id":2525,"MPAttachmentLetter":"A","Title":"HCPCS CODES FOR ANKLE-FOOT/ KNEE-ANKLE FOOT ORTHOSIS","MPPolicyAttachmentInternalSourceId":5397,"PolicyAttachmentPageName":"e5c855aa-09ff-43c6-8d25-61ea9d110409"},}
9f02b1b1-b4ae-4fb9-ba57-7b2967d1d6c2.aspx
  
2223AnorectalManometry,Electromyography(EMG)ofAnorectalorUrethralSphincters;BiofeedbackTrainingforPerinealMusclesandAnorectalorUrethralSphinctersMA07.018bMedicine (07)MA07.018bMA07.0189f02b1b1-b4ae-4fb9-ba57-7b2967d1d6c2Anorectal Manometry, Electromyography (EMG) of Anorectal or Urethral Sphincters; Biofeedback Training for Perineal Muscles and Anorectal or Urethral SphinctersAnorectal Manometry, Electromyography (EMG) of Anorectal or Urethral Sphincters; Biofeedback Training for Perineal Muscles and Anorectal or Urethral Sphincters
a8e854f7-94e7-4833-a02c-b7fb4214ff25.aspx
  
2179ApheresisTherapyMA06.001ePathology and Laboratory (06)MA06.001eMA06.001a8e854f7-94e7-4833-a02c-b7fb4214ff25Apheresis TherapyApheresis Therapy
3639d8b3-9067-4cd7-9c4c-e376655e9ed3.aspx
  
2098ApplicationandRemovalofTattoosMA11.072Surgery (11)MA11.072MA11.0723639d8b3-9067-4cd7-9c4c-e376655e9ed3Application and Removal of TattoosApplication and Removal of Tattoos
85257D39006E79458525854200771F5A.aspx
  
1647Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)MA08.091cMA08.09185257D39006E79458525854200771F5AAprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)
{"1800":{"Id":1800,"MPAttachmentLetter":"A","Title":"Risk of Emesis Without Prophylaxis: Intravenous and Oral Antineoplastic Agents","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E79458525854200771F88"},}
e5bdb582-1a6c-4cd1-935c-f5310b7873c8.aspx
  
2136AqueousShunts,Microstents,Viscocanalostomy,andCanaloplastyfortheTreatmentofGlaucomaMA11.105gSurgery (11)MA11.105gMA11.105e5bdb582-1a6c-4cd1-935c-f5310b7873c8Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaAqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
{"2137": {"Id":2137,"MPAttachmentLetter":"A","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":4937,"PolicyAttachmentPageName":"5182faf1-4a47-4c58-ae3f-33df15c64e88"},}
a4ae04b3-2afd-47d8-af6c-350cfb59df7f.aspx
  
2273ArtificialHeartsandVentricularAssistDevices(VADs)MA11.011dSurgery (11)MA11.011dMA11.011a4ae04b3-2afd-47d8-af6c-350cfb59df7fArtificial Hearts and Ventricular Assist Devices (VADs)Artificial Hearts and Ventricular Assist Devices (VADs)
ab7ba4a7-7b7e-477a-9b36-8be46c7597c1.aspx
  
2361ArtificialIntervertebralLumbarDiscInsertionMA11.114Surgery (11)MA11.114MA11.114ab7ba4a7-7b7e-477a-9b36-8be46c7597c1Artificial Intervertebral Lumbar Disc InsertionArtificial Intervertebral Lumbar Disc Insertion
167f3869-f6da-433d-9ab8-35366eec6588.aspx
  
2420AsparaginaseErwiniaChrysanthemi(Erwinaze®)MA08.085cPharmacy (08)MA08.085cMA08.085167f3869-f6da-433d-9ab8-35366eec6588Asparaginase Erwinia Chrysanthemi (Erwinaze®)Asparaginase Erwinia Chrysanthemi (Erwinaze®)
f4e0210e-b48a-4acf-bac3-8264b197062d.aspx
  
1935Atezolizumab(Tecentriq®)MA08.127Pharmacy (08)MA08.127MA08.127f4e0210e-b48a-4acf-bac3-8264b197062dAtezolizumab (Tecentriq®)Atezolizumab (Tecentriq®)
{"1936": {"Id":1936,"MPAttachmentLetter":"A","Title":"ICD-10 Codes and Narratives","MPPolicyAttachmentInternalSourceId":4730,"PolicyAttachmentPageName":"f86f9b92-feec-4d82-bc81-7fc3f03eb9ef"},}
46045ED869F1832F852585AB0056C456.aspx
  
1879Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)DME (05)MA05.005dMA05.00546045ED869F1832F852585AB0056C456Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)
{"1867": {"Id":1867,"MPAttachmentLetter":"A","Title":"ICD-10 codes used to represent the Wearable Automatic External Defibrillator (AED):","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"5801A106F8EA95A1852585AB0056C464"},"1868": {"Id":1868,"MPAttachmentLetter":"B","Title":"ICD-10 codes used to represent the Nonwearable Automatic External Defibrillator (AED):","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"BFE142D6DE3A8525852585AB0056C46C"},}
85257D39006E79458525853500666D0A.aspx
  
1325Autonomic Nervous System TestingMA07.027cMA07.02785257D39006E79458525853500666D0AAutonomic Nervous System TestingAutonomic Nervous System Testing
f91a2c3b-4f6b-4c15-b58c-6d05bcd97376.aspx
  
1921Avelumab(Bavencio®)MA08.122Pharmacy (08)MA08.122MA08.122f91a2c3b-4f6b-4c15-b58c-6d05bcd97376Avelumab (Bavencio®)Avelumab (Bavencio®)
{"1922": {"Id":1922,"MPAttachmentLetter":"A","Title":"ICD-10 Codes and Narratives","MPPolicyAttachmentInternalSourceId":4675,"PolicyAttachmentPageName":"765f7154-9f56-4ca8-bd28-3b9c1d7df492"},}
da677fd2-4630-47ac-af75-7526e365af35.aspx
  
2144BalloonCatheterDilationofSinusOstiaforTreatmentofChronicRhinosinusitisMA11.100eSurgery (11)MA11.100eMA11.100da677fd2-4630-47ac-af75-7526e365af35Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic RhinosinusitisBalloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis
190a4a96-ec61-4357-837d-aaec160f4469.aspx
  
2613belantamabmafodotin-blmf(Blenrep)MA08.119bPharmacy (08)MA08.119bMA08.119190a4a96-ec61-4357-837d-aaec160f4469belantamab mafodotin-blmf (Blenrep) belantamab mafodotin-blmf (Blenrep)
0406eaa8-0ae9-4fa6-8803-025b9cfefbf2.aspx
  
2494Belimumab(Benlysta®)forIntravenousUseMA08.057cPharmacy (08)MA08.057cMA08.0570406eaa8-0ae9-4fa6-8803-025b9cfefbf2Belimumab (Benlysta®) for Intravenous UseBelimumab (Benlysta®) for Intravenous Use
ced91d45-f963-4361-a204-a200fc6782bb.aspx
  
2421Bevacizumab(Avastin®)andRelatedBiosimilarsForOncologicUseMA08.072gPharmacy (08)MA08.072gMA08.072ced91d45-f963-4361-a204-a200fc6782bbBevacizumab (Avastin®) and Related Biosimilars For Oncologic UseBevacizumab (Avastin®) and Related Biosimilars For Oncologic Use
{"2422": {"Id":2422,"MPAttachmentLetter":"A","Title":"Dosing and Frequency Requirements","MPPolicyAttachmentInternalSourceId":5038,"PolicyAttachmentPageName":"54124135-9d23-4807-8bed-a767ac01f5b9"},}
c3346ad1-b72f-4800-9cb4-abec12bcb1ec.aspx
  
2343BillingforProfessionalOffice-BasedServicesPerformedinanOutpatientOffice-BasedSettingLocatedwithinaFacilityoronaFacilityCampusMA00.037jAdministrative (00)MA00.037jMA00.037c3346ad1-b72f-4800-9cb4-abec12bcb1ecBilling for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility CampusBilling for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus
{"2344": {"Id":2344,"MPAttachmentLetter":"A","Title":"Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus - CPT/HCPCS Codes","MPPolicyAttachmentInternalSourceId":5192,"PolicyAttachmentPageName":"b47ce025-9171-45e2-adc8-cc63cf0c3d6f"},}
c8e9390f-47a4-4253-ac7c-d1678698c4fa.aspx
  
2107BiofeedbackTherapyMA07.010aMedicine (07)MA07.010aMA07.010c8e9390f-47a4-4253-ac7c-d1678698c4faBiofeedback TherapyBiofeedback Therapy
85257D39006E7945852585350057717D.aspx
  
1625Bioimpedance for the Detection of LymphedemaMedicine (07)MA07.052MA07.05285257D39006E7945852585350057717DBioimpedance for the Detection of LymphedemaBioimpedance for the Detection of Lymphedema
81caf8fe-115d-4de8-b7d6-6eeeb38650ad.aspx
  
2417Blepharoplasty,RepairofBlepharoptosis,RepairofBrowPtosis,andCanthoplasty/CanthopexyMA11.047dSurgery (11)MA11.047dMA11.04781caf8fe-115d-4de8-b7d6-6eeeb38650adBlepharoplasty, Repair of Blepharoptosis, Repair of Brow Ptosis, and Canthoplasty/CanthopexyBlepharoplasty, Repair of Blepharoptosis, Repair of Brow Ptosis, and Canthoplasty/Canthopexy
{"2418": {"Id":2418,"MPAttachmentLetter":"A","Title":"ICD-10 Coding","MPPolicyAttachmentInternalSourceId":5007,"PolicyAttachmentPageName":"a24bd6c5-96b9-49b3-ab0d-a36c41d645b1"},}
3b7dd28d-6a20-406f-becc-281df3cd1732.aspx
  
2160Blinatumomab(Blincyto®)MA08.058cPharmacy (08)MA08.058cMA08.0583b7dd28d-6a20-406f-becc-281df3cd1732Blinatumomab (Blincyto®)Blinatumomab (Blincyto®)
a82f627b-608e-46e6-8a8d-739c2bcd90f4.aspx
  
2149Bone-Anchored(Osseointegrated)HearingAidsandImplantableMiddleEarHearingAidsMA11.049cSurgery (11)MA11.049cMA11.049a82f627b-608e-46e6-8a8d-739c2bcd90f4Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing AidsBone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
dd7b7c4d-7b78-402b-85dd-c547c40d1959.aspx
  
2584Bortezomib(BortezomibforInjection,Velcade®)MA08.037gPharmacy (08)MA08.037gMA08.037dd7b7c4d-7b78-402b-85dd-c547c40d1959Bortezomib (Bortezomib for Injection, Velcade®)Bortezomib (Bortezomib for Injection, Velcade®)
0593ec5d-f9c2-4ed5-bc83-5f36d09570ee.aspx
  
2610BotulinumToxinAgentsMA08.017fPharmacy (08)MA08.017fMA08.0170593ec5d-f9c2-4ed5-bc83-5f36d09570eeBotulinum Toxin AgentsBotulinum Toxin Agents
{"2611": {"Id":2611,"MPAttachmentLetter":"A","Title":"ICD-10 Diagnosis Codes","MPPolicyAttachmentInternalSourceId":5157,"PolicyAttachmentPageName":"a15e896e-9020-4a8a-b25c-687c2aeda3e7"},}
2dbb1a6c-5a4d-4740-ab89-669165aa125e.aspx
  
2463BrentuximabVedotin(Adcetris®)MA08.068ePharmacy (08)MA08.068eMA08.0682dbb1a6c-5a4d-4740-ab89-669165aa125eBrentuximab Vedotin (Adcetris®)Brentuximab Vedotin (Adcetris®)
{"2464": {"Id":2464,"MPAttachmentLetter":"A","Title":"ICD 10 CODES AND NARRATIVES","MPPolicyAttachmentInternalSourceId":5097,"PolicyAttachmentPageName":"5c0fa49d-3441-43ec-b1aa-a19c733a9201"},}
85257D39006E7945852585A400669A60.aspx
  
1363Bronchial ThermoplastySurgery (11)MA11.006bMA11.00685257D39006E7945852585A400669A60Bronchial ThermoplastyBronchial Thermoplasty
5d2c8f79-65d8-4f87-958e-20593b9da6d7.aspx
  
2493Burosumab-twza(Crysvita®)MA08.099bPharmacy (08)MA08.099bMA08.0995d2c8f79-65d8-4f87-958e-20593b9da6d7Burosumab-twza (Crysvita®)Burosumab-twza (Crysvita®)
da9e0793-604f-4c92-8e6c-21d765aac574.aspx
  
2449Canakinumab(Ilaris®)MA08.101aPharmacy (08)MA08.101aMA08.101da9e0793-604f-4c92-8e6c-21d765aac574Canakinumab (Ilaris®)Canakinumab (Ilaris®)
e7b87e7b-d3ea-4868-9135-b40a85b09ac6.aspx
  
2474CanesandCrutchesMA05.052bDME (05)MA05.052bMA05.052e7b87e7b-d3ea-4868-9135-b40a85b09ac6Canes and CrutchesCanes and Crutches
51e3d603-6f82-4751-8ea5-f1f85418b58c.aspx
  
2158CardiacRehabilitation(CR)andIntensiveCardiacRehabilitation(ICR)ProgramsMA10.002bRehabilitation Services (10)MA10.002bMA10.00251e3d603-6f82-4751-8ea5-f1f85418b58cCardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) ProgramsCardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs
{"2159": {"Id":2159,"MPAttachmentLetter":"A","Title":"Medically Necessary ICD-10 Codes","MPPolicyAttachmentInternalSourceId":4997,"PolicyAttachmentPageName":"6d739da0-31b5-49d0-ae21-af978b5be9c5"},}
dce37063-3216-4d24-942a-4765161f8650.aspx
  
2314CareManagementandCarePlanningServicesMA00.006hAdministrative (00)MA00.006hMA00.006dce37063-3216-4d24-942a-4765161f8650Care Management and Care Planning ServicesCare Management and Care Planning Services
e395dee3-755a-471c-b8f1-ddc066123e9e.aspx
  
2101Carfilzomib(Kyprolis™)MA08.062ePharmacy (08)MA08.062eMA08.062e395dee3-755a-471c-b8f1-ddc066123e9eCarfilzomib (Kyprolis™)Carfilzomib (Kyprolis™)
7a7e50a2-46a1-4673-b9d9-59a2fce39403.aspx
  
2236CastandSplintApplicationsandAssociatedSuppliesMA00.012cAdministrative (00)MA00.012cMA00.0127a7e50a2-46a1-4673-b9d9-59a2fce39403Cast and Splint Applications and Associated SuppliesCast and Splint Applications and Associated Supplies
{"2237": {"Id":2237,"MPAttachmentLetter":"A","Title":"Procedures Related to Cast and Splint Applications and Associated Supplies","MPPolicyAttachmentInternalSourceId":4985,"PolicyAttachmentPageName":"0a068e16-bb74-4ccb-9a5b-27b1dc464f75"},}
85257D39006E79458525857500659EB8.aspx
  
1297Cataract SurgerySurgery (11)MA11.054cMA11.05485257D39006E79458525857500659EB8Cataract SurgeryCataract Surgery
{"1821":{"Id":1821,"MPAttachmentLetter":"A","Title":"ICD-10 codes","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E79458525857500659EED"},}
3caf3ad6-1b9a-42aa-97ec-1a5e31058230.aspx
  
2112CatheterAblationofCardiacArrhythmiasMA11.060cSurgery (11)MA11.060cMA11.0603caf3ad6-1b9a-42aa-97ec-1a5e31058230Catheter Ablation of Cardiac ArrhythmiasCatheter Ablation of Cardiac Arrhythmias
85257D39006E79458525857B007B8F60.aspx
  
1880Cemiplimab-rwlc (LIBTAYO®)MA08.124MA08.12485257D39006E79458525857B007B8F60Cemiplimab-rwlc (LIBTAYO®)Cemiplimab-rwlc (LIBTAYO®)
819bf893-34cb-4721-bfb5-b8fbc37d603e.aspx
  
2629Cerliponasealfa(Brineura®)MA08.089cPharmacy (08)MA08.089cMA08.089819bf893-34cb-4721-bfb5-b8fbc37d603eCerliponase alfa (Brineura®)Cerliponase alfa (Brineura®)
d5768947-b18e-4bd3-a798-3b5a7af86d2c.aspx
  
2096CervicalTractionDevicesforIn-homeUseMA05.009aDME (05)MA05.009aMA05.009d5768947-b18e-4bd3-a798-3b5a7af86d2cCervical Traction Devices for In-home UseCervical Traction Devices for In-home Use
85257D39006E79458525846C00639663.aspx
  
1507Cetuximab (Erbitux®)Pharmacy (08)MA08.031dMA08.03185257D39006E79458525846C00639663Cetuximab (Erbitux®)Cetuximab (Erbitux®)
{"1762":{"Id":1762,"MPAttachmentLetter":"A","Title":"Dosing and Frequency Requirements","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E79458525846C0063966E"},"1763":{"Id":1763,"MPAttachmentLetter":"B","Title":"ICD-10 Codes for Cetuximab (Erbitux®)","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E79458525846C00639677"},}
f37d8c75-abe0-4d37-b0c0-c18d46ab4c17.aspx
  
2115ChemicalPeelsMA11.103aSurgery (11)MA11.103aMA11.103f37d8c75-abe0-4d37-b0c0-c18d46ab4c17Chemical PeelsChemical Peels
1e96c962-ecf5-462d-925f-711f62c2b728.aspx
  
2528ChimericAntigenReceptor(CAR)TherapyMA08.093gPharmacy (08)MA08.093gMA08.0931e96c962-ecf5-462d-925f-711f62c2b728Chimeric Antigen Receptor (CAR) TherapyChimeric Antigen Receptor (CAR) Therapy
{"2529": {"Id":2529,"MPAttachmentLetter":"A","Title":"ICD 10 codes","MPPolicyAttachmentInternalSourceId":5399,"PolicyAttachmentPageName":"7e2ab6bc-b2ad-4591-9ba7-e24d7cd50a8e"},}
f82146f9-0cf1-4da3-9708-df006eda0513.aspx
  
2057ChiropracticServicesMA10.004gRehabilitation Services (10)MA10.004gMA10.004f82146f9-0cf1-4da3-9708-df006eda0513Chiropractic ServicesChiropractic Services
{"2058": {"Id":2058,"MPAttachmentLetter":"A","Title":"Medically neessary ICD-10 diagnosis codes","MPPolicyAttachmentInternalSourceId":4853,"PolicyAttachmentPageName":"2eefa6a2-e9e7-4b20-b95e-7913990c9dc0"},}
F371FB2E48AFB33885257DBE00723399.aspx
  
1368Circulating Tumor Cell (CTC) AssayPathology and Laboratory (06)MA06.030MA06.030F371FB2E48AFB33885257DBE00723399Circulating Tumor Cell (CTC) AssayCirculating Tumor Cell (CTC) Assay
f8924323-e7d0-413d-a657-ace27100d002.aspx
  
2176CoagulationFactorsMA08.004rPharmacy (08)MA08.004rMA08.004f8924323-e7d0-413d-a657-ace27100d002Coagulation Factors Coagulation Factors
85257D39006E7945852585A400689511.aspx
  
1361Cobalamin (Vitamin B12), Folic Acid, and Homocysteine TestingMA06.032MA06.03285257D39006E7945852585A400689511Cobalamin (Vitamin B12), Folic Acid, and Homocysteine TestingCobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing
{"1859":{"Id":1859,"MPAttachmentLetter":"A","Title":"ICD 10 CODES FOR MEDICALLY NECESSARY COBALAMIN (VITAMIN B12), FOLIC ACID, AND/OR HOMOCYSTEINE TESTING (CPT CODES 82607, 82746, AND 83090)","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E7945852585A400689538"},}
2ff992d2-ca4a-42b9-b321-e387ed4804fd.aspx
  
2505CochlearImplantationMA11.039dSurgery (11)MA11.039dMA11.0392ff992d2-ca4a-42b9-b321-e387ed4804fdCochlear ImplantationCochlear Implantation
19b9a826-f613-4a37-9ef2-3b874f2f1b5a.aspx
  
2138Collagenaseclostridiumhistolyticum(Xiaflex®),collagenaseclostridiumhistolyticum-aaes(Qwo™)MA08.128Pharmacy (08)MA08.128MA08.12819b9a826-f613-4a37-9ef2-3b874f2f1b5aCollagenase clostridium histolyticum ( Xiaflex ®), collagenase clostridium histolyticum-aaes (Qwo™)Collagenase clostridium histolyticum ( Xiaflex ®), collagenase clostridium histolyticum-aaes (Qwo™)
e541d72d-63cc-41ee-8d00-eef69df90a9f.aspx
  
2476CommodeChairsMA05.036bDME (05)MA05.036bMA05.036e541d72d-63cc-41ee-8d00-eef69df90a9fCommode ChairsCommode Chairs
85257D39006E7945852585040068A7CD.aspx
  
1668Complementary and Integrative Health ServicesMiscellaneous (12)MA12.001dMA12.00185257D39006E7945852585040068A7CDComplementary and Integrative Health ServicesComplementary and Integrative Health Services
85257D39006E7945852584A1004F1618.aspx
  
1511Complete Decongestive Therapy (CDT)Medicine (07)MA07.042MA07.04285257D39006E7945852584A1004F1618Complete Decongestive Therapy (CDT)Complete Decongestive Therapy (CDT)
85257D39006E79458525853800640308.aspx
  
1293Composite Tissue Allotransplantation of the Hand(s) and FaceMA11.112MA11.11285257D39006E79458525853800640308Composite Tissue Allotransplantation of the Hand(s) and FaceComposite Tissue Allotransplantation of the Hand(s) and Face
85257D39006E7945852585510077B9C7.aspx
  
1355Compression GarmentsDME (05)MA05.045aMA05.04585257D39006E7945852585510077B9C7Compression GarmentsCompression Garments
85257D39006E7945852584F2004CAC60.aspx
  
1599Computer Aided Detection (CAD) System for Use with Chest RadiographsRadiology (09)MA09.014aMA09.01485257D39006E7945852584F2004CAC60Computer Aided Detection (CAD) System for Use with Chest RadiographsComputer Aided Detection (CAD) System for Use with Chest Radiographs
5fccb1cb-d1dd-433d-bebc-e409b6c643f4.aspx
  
2272Computer-AssistedMusculoskeletalSurgicalNavigationalOrthopedicProcedureMA11.088cSurgery (11)MA11.088cMA11.0885fccb1cb-d1dd-433d-bebc-e409b6c643f4Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic ProcedureComputer-Assisted Musculoskeletal Surgical Navigational Orthopedic Procedure
1a75604c-5542-4601-b256-9e702f9428ba.aspx
  
2041ConsultationServicesMA00.049Administrative (00)MA00.049MA00.0491a75604c-5542-4601-b256-9e702f9428baConsultation ServicesConsultation Services
85257D39006E7945852585BB0065691E.aspx
  
1875Continuous Glucose Monitors and Artificial Pancreas Device Systems (APDS)Administrative (00)MA00.002gMA00.00285257D39006E7945852585BB0065691EContinuous Glucose Monitors and Artificial Pancreas Device Systems (APDS)Continuous Glucose Monitors and Artificial Pancreas Device Systems (APDS)
{"1877": {"Id":1877,"MPAttachmentLetter":"A","Title":"ICD-10: Short term CGM","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E7945852585BB00657567"},"1878": {"Id":1878,"MPAttachmentLetter":"B","Title":"THERAPEUTIC LONG-TERM INTERSTITIAL CGMS","MPPolicyAttachmentInternalSourceId":0,"PolicyAttachmentPageName":"85257D39006E7945852585BB00657732"},}
16379ab5-1c4e-4ad3-9aa8-49dea5cd3d30.aspx
  
2532ContrastAgentsUsedinConjunctionwithEchocardiographyMA09.004cRadiology (09)MA09.004cMA09.00416379ab5-1c4e-4ad3-9aa8-49dea5cd3d30Contrast Agents Used in Conjunction with EchocardiographyContrast Agents Used in Conjunction with Echocardiography
e0f65852-e550-4adc-a4f3-d102b58690c0.aspx
  
2104CornealPachymetryUsingUltrasoundMA07.046fMedicine (07)MA07.046fMA07.046e0f65852-e550-4adc-a4f3-d102b58690c0Corneal Pachymetry Using UltrasoundCorneal Pachymetry Using Ultrasound
{"2105": {"Id":2105,"MPAttachmentLetter":"A","Title":"ICD-10-CM Codes Eligible to be Reported for Corneal Pachymetry Using Ultrasound","MPPolicyAttachmentInternalSourceId":4970,"PolicyAttachmentPageName":"1444f578-cd43-4d9b-8efc-e7fdbabdfb63"},}
ad0ebd72-6560-40a1-a162-47178bab8fd3.aspx
  
2119CosmeticProceduresMA12.009aMiscellaneous (12)MA12.009aMA12.009ad0ebd72-6560-40a1-a162-47178bab8fd3Cosmetic ProceduresCosmetic Procedures
85257D39006E7945852583F90064AAD0.aspx
  
1484Coverage of Medical DevicesDME (05)MA05.040bMA05.04085257D39006E7945852583F90064AAD0Coverage of Medical DevicesCoverage of Medical Devices
5d14dd79-3851-4eaf-bd7c-3896710bc679.aspx
  
2075CranialElectrotherapyStimulationMA05.066aDME (05)MA05.066aMA05.0665d14dd79-3851-4eaf-bd7c-3896710bc679Cranial Electrotherapy StimulationCranial Electrotherapy Stimulation
85257D39006E7945852584FD00658A7A.aspx
  
1616Criteria for Reimbursement of Emergency Room ServicesAdministrative (00)MA00.044bMA00.04485257D39006E7945852584FD00658A7ACriteria for Reimbursement of Emergency Room ServicesCriteria for Reimbursement of Emergency Room Services
aa45bf6d-52fb-45cd-9290-1f0466d9eb3d.aspx
  
2614crizanlizumab-tmca(Adakveo®)MA08.109aPharmacy (08)MA08.109aMA08.109aa45bf6d-52fb-45cd-9290-1f0466d9eb3dcrizanlizumab-tmca (Adakveo®)crizanlizumab-tmca (Adakveo®)
85257D39006E794585258535004D7D39.aspx
  
1630Cryosurgical Ablation of the Prostate GlandSurgery (11)MA11.022aMA11.02285257D39006E794585258535004D7D39Cryosurgical Ablation of the Prostate GlandCryosurgical Ablation of the Prostate Gland
85257D39006E79458525856F0067C06A.aspx
  
1882Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)Pharmacy (08)MA08.079fMA08.07985257D39006E79458525856F0067C06ADaratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)
47c29ee2-6b89-4781-9b06-f57ef31f898d.aspx
  
1955Daratumumab(Darzalex®),Daratumumab,andHyaluronidase-fihj(DarzalexFaspro™)MA08.079gPharmacy (08)MA08.079gMA08.07947c29ee2-6b89-4781-9b06-f57ef31f898dDaratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)
9e8d5417-cb7f-44f5-8b6a-111809f00afe.aspx
  
2327Daratumumab(Darzalex®),Daratumumab,andHyaluronidase-fihj(DarzalexFaspro™)MA08.079hPharmacy (08)MA08.079hMA08.0799e8d5417-cb7f-44f5-8b6a-111809f00afeDaratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™)
85257D39006E794585258588004883FD.aspx
  
1322Day RehabilitationRehabilitation Services (10)MA10.005bMA10.00585257D39006E794585258588004883FDDay RehabilitationDay Rehabilitation
16ca656e-5df1-4607-87cf-343264986af5.aspx
  
2485DebridementofMycoticandSymptomaticNon-MycoticHypertrophicToeNailsMA11.014fSurgery (11)MA11.014fMA11.01416ca656e-5df1-4607-87cf-343264986af5Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe NailsDebridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
{"2486": {"Id":2486,"MPAttachmentLetter":"E","Title":"ICD-10 CM Codes Eligible to be Reported for Debridement of mycotic hypertrophic toe nails (S86.892A - Z79.01), Continued","MPPolicyAttachmentInternalSourceId":5301,"PolicyAttachmentPageName":"0f26fb3b-4b4f-438f-baaf-4887a7a09cf5"},"2487": {"Id":2487,"MPAttachmentLetter":"C","Title":"ICD-10 CM Codes Eligible to be Reported for Debridement of mycotic hypertrophic toe nails (E13.3513 - I87.093), Continued","MPPolicyAttachmentInternalSourceId":5302,"PolicyAttachmentPageName":"03701af1-49b3-4ef5-9514-ff16d02d95d1"},"2488": {"Id":2488,"MPAttachmentLetter":"A","Title":"ICD-10 CM Codes Eligible to be Reported for Debridement of mycotic hypertrophic toe nails (A30.0 -E10.21)","MPPolicyAttachmentInternalSourceId":5303,"PolicyAttachmentPageName":"5e8475c6-da70-448e-af8e-bb27fc837a48"},"2489": {"Id":2489,"MPAttachmentLetter":"D","Title":"ICD-10 CM Codes Eligible to be Reported for Debridement of mycotic hypertrophic toe nails (I87.099 - S86.891S), Continued","MPPolicyAttachmentInternalSourceId":5304,"PolicyAttachmentPageName":"4f57eb6a-c04e-48c1-a7a7-e9f8362be969"},"2490": {"Id":2490,"MPAttachmentLetter":"B","Title":"ICD-10 CM Codes Eligible to be Reported for Debridement of mycotic hypertrophic toe nails (E10.22 - E13.3512), Continued","MPPolicyAttachmentInternalSourceId":5305,"PolicyAttachmentPageName":"26476cbd-bbca-4a96-b1c3-e9e92225ecb0"},}
16ffa733-0972-4703-be0f-1baa1a71f1f5.aspx
  
2079DeepBrainStimulation(DBS)MA11.005dSurgery (11)MA11.005dMA11.00516ffa733-0972-4703-be0f-1baa1a71f1f5Deep Brain Stimulation (DBS)Deep Brain Stimulation (DBS)
04571c73-0e06-47e3-9709-e9ecdfa492d1.aspx
  
2627Denosumab(Prolia®,Xgeva®),Romosozumab-aqqg(Evenity®)MA08.052iPharmacy (08)MA08.052iMA08.05204571c73-0e06-47e3-9709-e9ecdfa492d1Denosumab (Prolia®, Xgeva®), Romosozumab-aqqg (Evenity®)Denosumab (Prolia®, Xgeva®), Romosozumab-aqqg (Evenity®)
{"2628": {"Id":2628,"MPAttachmentLetter":"A","Title":"ICD-10-CM Codes","MPPolicyAttachmentInternalSourceId":5351,"PolicyAttachmentPageName":"a69416c2-5469-4c42-b7c4-ac0f1de7400d"},}
855c3dd7-e21c-4c80-966f-b8c6a15a3472.aspx
  
2334DirectAccesstoObstetrics/Gynecology(OB/GYN)ServicesMA00.032cAdministrative (00)MA00.032cMA00.032855c3dd7-e21c-4c80-966f-b8c6a15a3472Direct Access to Obstetrics/Gynecology (OB/GYN) ServicesDirect Access to Obstetrics/Gynecology (OB/GYN) Services
{"2335": {"Id":2335,"MPAttachmentLetter":"A","Title":"Procedure Code for Direct Access OB/GYN for Family Planning","MPPolicyAttachmentInternalSourceId":5194,"PolicyAttachmentPageName":"5f3e1a47-9b97-475d-a095-45b97f6c7876"},}
85257D39006E7945852585A4006756E7.aspx
  
1362Dofetilide (Tikosyn®) Use in the Inpatient SettingPharmacy (08)MA08.021bMA08.02185257D39006E7945852585A4006756E7Dofetilide (Tikosyn®) Use in the Inpatient SettingDofetilide (Tikosyn®) Use in the Inpatient Setting
d23692bf-87f2-46e4-9ee8-4c39765b6b8d.aspx
  
2093Drug-ElutingBeadsandBlandEmbolizationfortheTreatmentofHepaticMalignanciesMA07.041bMedicine (07)MA07.041bMA07.041d23692bf-87f2-46e4-9ee8-4c39765b6b8dDrug-Eluting Beads and Bland Embolization for the Treatment of Hepatic MalignanciesDrug-Eluting Beads and Bland Embolization for the Treatment of Hepatic Malignancies
596a60fd-ea68-4604-8262-7e7a662837a8.aspx
  
2552DurableMedicalEquipment(DME)MA05.044jDME (05)MA05.044jMA05.044596a60fd-ea68-4604-8262-7e7a662837a8Durable Medical Equipment (DME)Durable Medical Equipment (DME)
{"2553": {"Id":2553,"MPAttachmentLetter":"B","Title":"Items that Do Not Meet the Definition of Durable Medical Equipment (DME) or Excluded from Coverage by Medicare","MPPolicyAttachmentInternalSourceId":5444,"PolicyAttachmentPageName":"f7083114-f877-4261-a43b-01a976c4847b"},"2554": {"Id":2554,"MPAttachmentLetter":"A2","Title":"Equipment that Meets the Definition of Durable Medical Equipment (DME)","MPPolicyAttachmentInternalSourceId":5445,"PolicyAttachmentPageName":"86a0554d-9174-4cfe-a70b-e6ff57c756a5"},"2555": {"Id":2555,"MPAttachmentLetter":"A1","Title":"Equipment that Meets the Definition of Durable Medical Equipment (DME)","MPPolicyAttachmentInternalSourceId":5446,"PolicyAttachmentPageName":"4f5a6c9f-6370-4d60-abc1-bfc7b9116c5f"},}
81644841-0f55-4dc1-9476-5ab8d631fd3a.aspx
  
2423DurableMedicalEquipment(DME)NotSubjecttoaRentaltoPurchaseMaximumMA05.028eDME (05)MA05.028eMA05.02881644841-0f55-4dc1-9476-5ab8d631fd3aDurable Medical Equipment (DME) Not Subject to a Rental to Purchase MaximumDurable Medical Equipment (DME) Not Subject to a Rental to Purchase Maximum
2cc301d3-5baf-4ab6-a6a5-21ce1991f10d.aspx
  
1923Durvalumab(Imfinzi™)MA08.123Pharmacy (08)MA08.123MA08.1232cc301d3-5baf-4ab6-a6a5-21ce1991f10dDurvalumab (Imfinzi™)Durvalumab (Imfinzi™)
{"1924": {"Id":1924,"MPAttachmentLetter":"A","Title":"ICD-10 Codes and Narratives","MPPolicyAttachmentInternalSourceId":4686,"PolicyAttachmentPageName":"2c353d16-201e-4684-9657-003c3bef9330"},}
85257D39006E7945852584C800670CC3.aspx
  
1657Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris™)Pharmacy (08)MA08.044fMA08.04485257D39006E7945852584C800670CC3Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris™)Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris™)
43933fd6-a89a-46a8-89a2-430e9625b5f6.aspx
  
1908Edaravone(Radicava™)MA08.092aPharmacy (08)MA08.092aMA08.09243933fd6-a89a-46a8-89a2-430e9625b5f6Edaravone (Radicava™)Edaravone (Radicava™)
d0ed73a0-1d77-4f22-9d58-a33008362521.aspx
  
2454ElectricalContinenceAidMA05.059DME (05)MA05.059MA05.059d0ed73a0-1d77-4f22-9d58-a33008362521Electrical Continence AidElectrical Continence Aid
1c69392b-48d0-4d1f-8932-d5360da9dd64.aspx
  
2024ElectricalStimulationandElectromagneticStimulationfortheTreatmentofWoundsMA07.013dMedicine (07)MA07.013dMA07.0131c69392b-48d0-4d1f-8932-d5360da9dd64Electrical Stimulation and Electromagnetic Stimulation for the Treatment of WoundsElectrical Stimulation and Electromagnetic Stimulation for the Treatment of Wounds
{"2025": {"Id":2025,"MPAttachmentLetter":"A","Title":"ICD-10 Coding","MPPolicyAttachmentInternalSourceId":4740,"PolicyAttachmentPageName":"deaa6ae5-bf82-4891-b265-fd8a22603956"},}
2b34f47b-170d-4497-a27b-e2473db10dfd.aspx
  
2180Electromyography(EMG)Studies:NeedleEMG,SurfaceEMG(SEMG)MA07.050gMedicine (07)MA07.050gMA07.0502b34f47b-170d-4497-a27b-e2473db10dfdElectromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG)Electromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG)
{"2181": {"Id":2181,"MPAttachmentLetter":"G","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5053,"PolicyAttachmentPageName":"726854b6-9990-4be5-b5ba-67cc672d6de3"},"2182": {"Id":2182,"MPAttachmentLetter":"F","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5054,"PolicyAttachmentPageName":"bfc3b8ab-79b3-4253-91d8-ec5865d2e9b7"},"2183": {"Id":2183,"MPAttachmentLetter":"D","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5055,"PolicyAttachmentPageName":"c8e3f9f7-61db-44eb-9f24-76677912c805"},"2184": {"Id":2184,"MPAttachmentLetter":"C","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5056,"PolicyAttachmentPageName":"b5e97c0f-1d18-4a2e-9019-2d7fffa0d991"},"2185": {"Id":2185,"MPAttachmentLetter":"A","Title":"Recommended Guidelines for Electrodiagnostic Studies","MPPolicyAttachmentInternalSourceId":5057,"PolicyAttachmentPageName":"5fdaac7d-0d77-4f9d-aab5-24285ca077aa"},"2186": {"Id":2186,"MPAttachmentLetter":"B","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5058,"PolicyAttachmentPageName":"3b049e48-b578-4525-82a7-62726c63c5ff"},"2187": {"Id":2187,"MPAttachmentLetter":"I","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5059,"PolicyAttachmentPageName":"31c08e58-bc44-4176-8d94-73a9bb4f606e"},"2188": {"Id":2188,"MPAttachmentLetter":"H","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5060,"PolicyAttachmentPageName":"b435fccd-0aaa-493b-8981-d238f7516ae2"},"2189": {"Id":2189,"MPAttachmentLetter":"K","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5061,"PolicyAttachmentPageName":"2ca859a1-a341-4354-bf28-a9db789272e3"},"2190": {"Id":2190,"MPAttachmentLetter":"E","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5062,"PolicyAttachmentPageName":"95377478-0472-4075-8201-a63c067ccf58"},"2191": {"Id":2191,"MPAttachmentLetter":"J","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":5063,"PolicyAttachmentPageName":"6e14e80f-8e3b-46dd-a081-21d429929585"},}
7db73249-b6ca-4bca-bc82-51af7fac9622.aspx
  
1931ElectronBeamComputedTomography(EBCT)forScreeningEvaluationsMA09.011aRadiology (09)MA09.011aMA09.0117db73249-b6ca-4bca-bc82-51af7fac9622Electron Beam Computed Tomography (EBCT) for Screening EvaluationsElectron Beam Computed Tomography (EBCT) for Screening Evaluations
59432da8-ece6-47a2-b673-19a3b614d8f0.aspx
  
2630Emapalumab-lzsg(Gamifant®)MA08.104bPharmacy (08)MA08.104bMA08.10459432da8-ece6-47a2-b673-19a3b614d8f0Emapalumab-lzsg (Gamifant®)Emapalumab-lzsg (Gamifant®)
85257D39006E7945852585430048116B.aspx
  
1654Endometrial AblationSurgery (11)MA11.065dMA11.06585257D39006E7945852585430048116BEndometrial AblationEndometrial Ablation
1 - 100Next